- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/58 - Protease inhibitors from animalsProtease inhibitors from humans from leeches, e.g. hirudin, eglin
Patent holdings for IPC class A61K 38/58
Total number of patents in this class: 58
10-year publication summary
|
7
|
2
|
5
|
2
|
3
|
6
|
7
|
5
|
3
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 959 |
4 |
| Maia Pharmaceuticals, Inc. | 25 |
4 |
| Universite Catholique de Louvain | 294 |
3 |
| The University of British Columbia | 1537 |
3 |
| The Trustees of the University of Pennsylvania | 4414 |
2 |
| Case Western Reserve University | 1888 |
2 |
| The Heart Research Institute Ltd | 27 |
2 |
| Lunan Pharmaceutical Group Corporation | 45 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
2 |
| Virologik GmbH | 5 |
2 |
| Novartis AG | 10263 |
1 |
| Novartis Pharma AG | 226 |
1 |
| Abbott Cardiovascular Systems, Inc. | 1022 |
1 |
| Duke University | 3184 |
1 |
| Acceleron Pharma Inc. | 341 |
1 |
| Aronora, Inc. | 16 |
1 |
| Children's Hospital Medical Center | 746 |
1 |
| Children's Medical Center Corporation | 1956 |
1 |
| CSL Behring GmbH | 346 |
1 |
| Imperial Innovations Limited | 549 |
1 |
| Other owners | 22 |